Hi,
That looks very promising and soon we can get back to business as usual !?
I recently found a publication online by Hoffmann et al. which appeared on March 5, 2020
in the journal Cell : SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Article SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blo...
I was very glad to see that. -- Emanuel